Abstract
While elevated arterial stiffness is recognized as a predictor of atrial fibrillation (AF), the relationship between long-term pulse pressure (PP) and the incidence of AF remains to be fully elucidated. We assessed the influence of time-averaged cumulative PP in midlife on incident AF. The analysis included 9150 adults from the Atherosclerosis Risk in Communities (ARIC) cohort who were free of AF at visit 4. The time-averaged cumulative blood pressure (BP) was calculated as the sum of the averaged BPs from the adjacent consecutive visits (visits 1–4), with the values being indexed to the total exposure time. At visit 4, the mean age of the study population was 62.9 years, with 4045 (44.2%) of the population being male. In 1455 individuals (15.9%) with a median follow-up of 16 years, incident AF was seen. The greatest predictor of incident AF, as indicated by the decline in the −2 Log likelihood statistic, was time-averaged cumulative PP, which was linked to an elevated risk for AF (HR = 1.20 (1.13–1.27)) in adjusted Cox models (per 1-SD increment). The correlation between incident AF and time-averaged cumulative systolic blood pressure (SBP) was 1.14 (1.07–1.22). In contrast, the diastolic relation tended to be opposite (HR = 0.94 (0.88–1.00)). Moreover, among persons aged < 65 years, without hypertension or antihypertensive treatment, these associations were even more remarkable (P < 0.05 for all interactions). Time-averaged cumulative PP in midlife was an important risk factor for incident AF with the strongest predictive effect, especially in persons who were younger, normotensive, or without antihypertensive treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
Data availability
Additional data are available from the corresponding author on reasonable request.
References
Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129:837–47.
Zimetbaum P. Atrial fibrillation. Ann Intern Med. 2017;166:Itc33–Itc48.
Lip GY, Fauchier L, Freedman SB, Van Gelder I, Natale A, Gianni C, et al. Atrial fibrillation. Nat Rev Dis Primers. 2016;2:16016.
Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation: the framingham heart study. Circulation. 2004;110:1042–6.
Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the rotterdam study. Eur Heart J. 2006;27:949–53.
Cremer A, Lainé M, Papaioannou G, Yeim S, Gosse P. Increased arterial stiffness is an independent predictor of atrial fibrillation in hypertensive patients. J Hypertens. 2015;33:2150–5.
Mitchell GF, Vasan RS, Keyes MJ, Parise H, Wang TJ, Larson MG, et al. Pulse pressure and risk of new-onset atrial fibrillation. JAMA. 2007;297:709–15.
Larstorp AC, Ariansen I, Gjesdal K, Olsen MH, Ibsen H, Devereux RB, et al. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the losartan intervention for endpoint (life) reduction in hypertension study. Hypertension. 2012;60:347–53.
Valbusa F, Bonapace S, Bertolini L, Zenari L, Arcaro G, Targher G. Increased pulse pressure independently predicts incident atrial fibrillation in patients with type 2 diabetes. Diabetes Care. 2012;35:2337–9.
Nuotio J, Suvila K, Cheng S, Langén V, Niiranen T. Longitudinal blood pressure patterns and cardiovascular disease risk. Ann Med. 2020;52:43–54.
Pool LR, Ning H, Wilkins J, Lloyd-Jones DM, Allen NB. Use of long-term cumulative blood pressure in cardiovascular risk prediction models. JAMA Cardiol. 2018;3:1096–1100.
Mahinrad S, Kurian S, Garner CR, Sedaghat S, Nemeth AJ, Moscufo N, et al. Cumulative blood pressure exposure during young adulthood and mobility and cognitive function in midlife. Circulation. 2020;141:712–24.
Yaffe K, Vittinghoff E, Pletcher MJ, Hoang TD, Launer LJ, Whitmer R, et al. Early adult to midlife cardiovascular risk factors and cognitive function. Circulation. 2014;129:1560–7.
Wang YX, Song L, Xing AJ, Gao M, Zhao HY, Li CH, et al. Predictive value of cumulative blood pressure for all-cause mortality and cardiovascular events. Sci Rep. 2017;7:41969.
Nwabuo CC, Appiah D, Moreira HT, Vasconcellos HD, Yano Y, Reis JP, et al. Long-term cumulative blood pressure in young adults and incident heart failure, coronary heart disease, stroke, and cardiovascular disease: The cardia study. Eur J Prev Cardiol. 2021;28:1445–51.
Teramoto K, Nadruz Junior W, Matsushita K, Claggett B, John JE, Skali H, et al. Mid- to late-life time-averaged cumulative blood pressure and late-life cardiac structure, function, and heart failure. Hypertension. 2020;76:808–18.
Vasconcellos HD, Moreira HT, Ciuffo L, Nwabuo CC, Yared GS, Ambale-Venkatesh B, et al. Cumulative blood pressure from early adulthood to middle age is associated with left atrial remodelling and subclinical dysfunction assessed by three-dimensional echocardiography: a prospective post hoc analysis from the coronary artery risk development in young adults study. Eur Heart J Cardiovasc Imaging. 2018;19:977–84.
Kishi S, Teixido-Tura G, Ning H, Venkatesh BA, Wu C, Almeida A, et al. Cumulative blood pressure in early adulthood and cardiac dysfunction in middle age: the cardia study. J Am Coll Cardiol. 2015;65:2679–87.
Rosamond WD, Folsom AR, Chambless LE, Wang CH. Coronary heart disease trends in four united states communities. The atherosclerosis risk in communities (aric) study 1987-1996. Int J Epidemiol. 2001;30:S17–22.
The atherosclerosis risk in communities (aric) study: Design and objectives. The aric investigators. Am J Epidemiol. 1989;129:687–702.
Petruski-Ivleva N, Viera AJ, Shimbo D, Muntner P, Avery CL, Schneider AL, et al. Longitudinal patterns of change in systolic blood pressure and incidence of cardiovascular disease: the atherosclerosis risk in communities study. Hypertension. 2016;67:1150–6.
Zemaitis P, Liu K, Jacobs DR Jr., Cushman M, Durazo-Arvizu R, Shoham D, et al. Cumulative systolic bp and changes in urine albumin-to-creatinine ratios in nondiabetic participants of the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol. 2014;9:1922–9.
Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ, et al. Incidence of atrial fibrillation in whites and african-americans: the atherosclerosis risk in communities (aric) study. Am Heart J. 2009;158:111–7.
Vanezis AP, Bhopal R. Validity of electrocardiographic classification of left ventricular hypertrophy across adult ethnic groups with echocardiography as a standard. J Electrocardiol. 2008;41:404–12.
Wright JT Jr., Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–16.
Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513–8.
Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet. 1987;1:581–4.
Stewart IM. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet. 1979;1:861–5.
Messerli FH, Panjrath GS. The j-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J Am Coll Cardiol. 2009;54:1827–34.
Vaziri SM, Larson MG, Lauer MS, Benjamin EJ, Levy D. Influence of blood pressure on left atrial size. The framingham heart study. Hypertension. 1995;25:1155–60.
Eijsbouts SC, Majidi M, van, Zandvoort M, Allessie MA. Effects of acute atrial dilation on heterogeneity in conduction in the isolated rabbit heart. J Cardiovasc Electrophysiol. 2003;14:269–78.
Huang JL, Tai CT, Chen JT, Ting CT, Chen YT, Chang MS, et al. Effect of atrial dilatation on electrophysiologic properties and inducibility of atrial fibrillation. Basic Res Cardiol. 2003;98:16–24.
Cheng S, Xanthakis V, Sullivan LM, Vasan RS. Blood pressure tracking over the adult life course: patterns and correlates in the framingham heart study. Hypertension. 2012;60:1393–9.
Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension. 1998;32:560–4.
Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in olmsted county, minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–25.
Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The framingham heart study. JAMA. 1994;271:840–4.
Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96:2455–61.
Zhang S, Zhuang X, Lin X, Zhong X, Zhou H, Sun X, et al. Low-carbohydrate diets and risk of incident atrial fibrillation: a prospective cohort study. J Am Heart Assoc. 2019;8:e011955.
Acknowledgements
We thank the staff and participants of the ARIC study (Atherosclerosis Risk in Communities) for their important contribution.
FUNDING
This study was supported by the National Natural Science Foundation of China (81870195, 82070384 to X.Liao; 81900329 to Y.Guo), Guangdong Basic and Applied Basic Research Foundation (2019A1515011582, 2021A1515011668 to X.Liao; 2019A1515011098, 2022A1515010416 to Y.Guo; 2021A1515110266 to Z. Xiong), the China Postdoctoral Science special Foundation funded project (2021TQ0386, 2021M703738 to Z. Xiong).
Author information
Authors and Affiliations
Contributions
ZZ, YH, XZ and XL conceived and designed the study, interpreted the data and wrote the manuscript. YL, SZ, ZX, ML, WZ and YG interpreted the data and revised the manuscript draft for important intellectual content. All authors agree to be fully accountable for ensuring the integrity and accuracy of the work, and read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
This study involved human participants and was approved by institutional review boards at all participating institutions in the Atherosclerosis Risk in Communities (ARIC) study as well as by a review panel at the National Heart, Lung, and Blood Institute (NHLBI). The current analysis of the ARIC study data was approved by IEC for Clinical Research and Animal Trials of the First Affiliated Hospital of Sun Yat-Sen University (2020429). Participants provided written informed consent. All methods were performed in accordance with the relevant guidelines and regulations.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Huang, Y., Zhou, Z., Lin, Y. et al. Time-averaged cumulative pulse pressure in midlife and incident atrial fibrillation: the atherosclerosis risk in communities study. J Hum Hypertens 40, 23–28 (2026). https://doi.org/10.1038/s41371-025-01050-4
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41371-025-01050-4


